TABLE I.
Patient characteristics
| Variable | Control | Intervention |
|---|---|---|
| Patients (n) | 24 | 26 |
| Sex [n (%) men] | 11 (46) | 23 (88) |
| Age (years) | ||
| Median | 56 | 56.3 |
| Range | 30–72 | 36–70 |
| Mean | 56±8.6 | 56.5±9.6 |
| Mean weight (kg) | 77.3±19.5 | 84.0±10.9 |
| Diagnosis [n (%)] | ||
| Non-Hodgkin lymphoma | 7 (29.1) | 6 (23.1) |
| Multiple myeloma | 15 (62.5) | 18 (69.2) |
| Acute myeloid leukemia | 1 (4.2) | 0 (0) |
| Breast cancer | 1 (4.2) | 0 (0) |
| Other | 0 (0) | 2 (7.7) |
| Conditioning regimen [n (%)] | ||
| Melphalan 200 mg/m2 | 16 (66.7) | 19 (73.1) |
| beama | 5 (20.8) | 2 (7.7) |
| Busulphan–melphalan | 2 (8.3) | 5 (19.2) |
| Other | 1 (4.2) | 0 (0) |
a
Carmustine, etoposide, cytarabine, melphalan.